Print
Effects of Occupational Therapy Telehealth Intervention on Cancer-Related Cognitive Impairment in Breast Cancer Survivors
https://www.facingourrisk.org/research-clinical-trials/study/225/effects-of-occupational-therapy-telehealth-intervention-on-cancer-related-cognitive-impairment-in-breast-cancer-survivors
Clinicaltrials.gov identifier:
NCT05505045 (https://clinicaltrials.gov/show/NCT05505045)
Quality of Life
Telehealth study for breast cancer survivors with memory issues
Study Contact Information:
PI: Dr. Anna Boone
Email: [email protected]
Phone: 573-882-7023
About the Study
The purpose of this study is to look at the effects and ease of use of occupational therapy delivered by telehealth on activity performance, memory and quality of life in breast cancer survivors. Participants will complete all sessions from home via Zoom videoconferencing. This is a 2-arm randomized control trial, which means that each participant will be randomly assigned to one of two groups. Participants will complete the same number of sessions regardless of which group they are assigned to.
What the Study Involves
- This study will last for about 12 weeks.
- Participants in both treatment groups will participate in 10 weekly sessions. Each session will last approximately 45-60 minutes. Participants will complete all sessions from home via Zoom videoconferencing.
- Participants in both treatment groups will complete an assessment session both before and after the intervention. The first assessment session (completed before treatment) will last approximately 2.5 hours. The second assessment session (completed after treatment) will last approximately 2 hours. Participants will receive $75 for completing each of these sessions, for a total of $150 for completing the study in its entirety. The assessments will consist of questionnaires, interviews, and thinking tests. Both assessment sessions will be completed at home via Zoom videoconferencing.
Study Locations
- This is a telehealth study being conducted by researchers at the University of Missouri-Columbia Department of Occupational Therapy. Anyone who lives in the United States and meets eligibility criteria may participate.
- If interested, please contact the study coordinator, Juliana Hudson, at [email protected] or 573-884-6681.
Lead Researcher
Dr. Anna Boone, PhD, MSOT, OTR/L
University of Missouri-Columbia
Email: [email protected]
Phone: 573-882-7023
This Study is Open To:
- Women between 40-80 years old
- Have a previous diagnosis of breast cancer
- Completed a full course of chemotherapy between 6 months and 3 years ago
- Experience memory challenges since completing chemotherapy
This Study is Not Open To:
Participants are not eligible if they:
- Are not able to read, write, and speak English fluently
- Have changed medications within the past 60 days
- Have a previous diagnosis of any other cancer
- Have any other neurological conditions
About FORCE
FORCE is a national nonprofit organization, established in 1999. Our mission is to improve the lives of individuals and families affected by adult hereditary cancers.
